Xing Gao

530 total citations
41 papers, 394 citations indexed

About

Xing Gao is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xing Gao has authored 41 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xing Gao's work include Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (8 papers). Xing Gao is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (8 papers). Xing Gao collaborates with scholars based in China, Netherlands and Taiwan. Xing Gao's co-authors include Yun Cai, Zejun Liu, Yujie Zhang, Hongyu Zhu, Jianhua Chen, Zhihui Li, Shi Qiu, Jing Qi, Yin‐Kai Chao and Xuepeng Fan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and ACS Applied Materials & Interfaces.

In The Last Decade

Xing Gao

37 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Gao China 12 199 113 78 74 68 41 394
Zoi Kanaki Greece 9 253 1.3× 109 1.0× 128 1.6× 67 0.9× 47 0.7× 19 510
Shaomin Che China 12 155 0.8× 112 1.0× 37 0.5× 57 0.8× 57 0.8× 17 355
Chengliang Zhao China 12 105 0.5× 101 0.9× 92 1.2× 81 1.1× 130 1.9× 32 407
Yangmeihui Song China 14 196 1.0× 145 1.3× 88 1.1× 83 1.1× 79 1.2× 27 498
Christopher Jackson United States 8 124 0.6× 83 0.7× 63 0.8× 57 0.8× 33 0.5× 15 297
Kun Mi China 11 152 0.8× 117 1.0× 34 0.4× 66 0.9× 43 0.6× 19 355
Man Li China 11 122 0.6× 83 0.7× 33 0.4× 44 0.6× 59 0.9× 28 316
Bingqiang Gao China 10 137 0.7× 69 0.6× 63 0.8× 52 0.7× 78 1.1× 21 401

Countries citing papers authored by Xing Gao

Since Specialization
Citations

This map shows the geographic impact of Xing Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Gao more than expected).

Fields of papers citing papers by Xing Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Gao. The network helps show where Xing Gao may publish in the future.

Co-authorship network of co-authors of Xing Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Gao. A scholar is included among the top collaborators of Xing Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Gao. Xing Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Taiyi, Yingying Jing, Yen Leng Pak, et al.. (2025). Room-temperature phosphorescence based on doping systems: material design, mechanisms, and applications. Materials Chemistry Frontiers. 10(4). 538–564.
2.
Chen, Xinzhe, Hongfei Xu, Xuemei Zhao, et al.. (2025). PYRCR alleviates myocardial ischemia/reperfusion injury in mice via inhibiting DRG2-mediated cardiomyocyte pyroptosis. Acta Pharmacologica Sinica. 46(12). 3204–3216. 3 indexed citations
4.
Gao, Xing, Ben M. Eyck, Daan Nieboer, et al.. (2024). Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis. British journal of surgery. 111(5). 1 indexed citations
5.
Tagkalos, Evangelos, Peter Grimminger, Xing Gao, et al.. (2024). Incidence and Predictors of Textbook Outcome after Minimally Invasive Esophagectomy for Cancer: A Two-Center Study. Cancers. 16(6). 1109–1109. 2 indexed citations
6.
Zhang, Mingjia, Yixuan Cui, Ru Jia, et al.. (2024). Hesperidin alleviated dendritic spines through inhibiting ferritinophagy via HERC2-NCOA4 ubiquitination in CUMS mice. Phytomedicine. 135. 156132–156132. 2 indexed citations
7.
Leng, Xuefeng, Daisuke Kurita, Yi Zhu, et al.. (2023). Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases. Journal of Thoracic Disease. 15(11). 6362–6372. 1 indexed citations
10.
Lu, Can, Xiang He, Lin Wei, et al.. (2023). E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC. Cell Reports. 42(12). 113477–113477. 13 indexed citations
11.
Gao, Xing, et al.. (2023). Survival Outcomes of Patients with Esophageal Cancer Who Did Not Proceed to Surgery after Neoadjuvant Treatment. Cancers. 15(16). 4049–4049. 1 indexed citations
13.
Eyck, Ben M., Xing Gao, Yang Yang, et al.. (2022). Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison. British journal of surgery. 109(12). 1312–1318. 11 indexed citations
14.
Gao, Xing, Yu‐Wen Wen, J. Jan B. van Lanschot, & Yin‐Kai Chao. (2022). Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis. Annals of Surgical Oncology. 29(6). 3644–3653.
15.
Gao, Xing, Jeroen de Jonge, Hence J.M. Verhagen, et al.. (2021). Unsuccessful Stent Graft Repair of a Hepatic Artery Aneurysm Presenting with Haemobilia: Case Report and Comprehensive Literature Review. EJVES Vascular Forum. 52. 30–36. 4 indexed citations
17.
Xie, Binbin, Bingjun Bai, Yuzi Xu, et al.. (2019). Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer. Signal Transduction and Targeted Therapy. 4(1). 51–51. 30 indexed citations
19.
Liu, Zejun, Gang Wang, Yun Cai, et al.. (2009). Androgen Receptor CpG Island Methylation Status in Human Leukemia Cancer Cells. Cancer Investigation. 27(2). 156–162. 8 indexed citations
20.
Liu, Zejun, Xing Gao, Yun Cai, et al.. (2009). Construction of a full-length iASPP expression plasmid pcDNA3.1(+)/iASPP and its biological activity. Plasmid. 62(1). 10–15. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026